Search research articles
Contact Us
Filters
Showing results (721-730 of 735) with videos related to
Page
of 74
Sort By:
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
February 11, 2026
Long-term disease progression in pediatric acute recurrent and chronic pancreatitis: A report from INSPPIRE
Elissa M Downs, Emily R Perito, Fuchenchu Wang, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 30, 2025
Utility and utilization of transabdominal ultrasound in pediatric patients with acute recurrent or chronic pancreatitis
Nicholas Norris, David Troendle, Michael Wilschanski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
The Journal of Pediatrics
|
September 14, 2024
Impact of Elevated Serum Triglycerides on Children with Acute Recurrent or Chronic Pancreatitis from INSPPIRE-2
Zachary M Sellers, Matthew J Giefer, Fuchenchu Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 16, 2026
Pancreatitis Risk Genes Play a Major Role in Pediatric Pancreatitis: Insights From INSPPIRE
Maisam Abu-El-Haija, Wenying Zhang, Fuchenchu Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Philippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer
Elaine Chang, Noah M Hahn, Seth P Lerner, et al.
The Journal of Urology
|
May 5, 2024
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial
Vikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, et al.
The Lancet. Oncology
|
November 30, 2020
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, et al.
Page
of 74
Search research articles
Search
Showing results (721-730 of 735) with videos related to
Sort By:
Page
of 74
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
February 11, 2026
Long-term disease progression in pediatric acute recurrent and chronic pancreatitis: A report from INSPPIRE
Elissa M Downs, Emily R Perito, Fuchenchu Wang, et al.
Journal of Pediatric Gastroenterology and Nutrition
|
November 30, 2025
Utility and utilization of transabdominal ultrasound in pediatric patients with acute recurrent or chronic pancreatitis
Nicholas Norris, David Troendle, Michael Wilschanski, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 6, 2020
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
The Journal of Pediatrics
|
September 14, 2024
Impact of Elevated Serum Triglycerides on Children with Acute Recurrent or Chronic Pancreatitis from INSPPIRE-2
Zachary M Sellers, Matthew J Giefer, Fuchenchu Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 16, 2026
Pancreatitis Risk Genes Play a Major Role in Pediatric Pancreatitis: Insights From INSPPIRE
Maisam Abu-El-Haija, Wenying Zhang, Fuchenchu Wang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 6, 2018
NCCN Guidelines Insights: Bladder Cancer, Version 5.2018
Thomas W Flaig, Philippe E Spiess, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 7, 2017
Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
Philippe E Spiess, Neeraj Agarwal, Rick Bangs, et al.
Bladder Cancer (Amsterdam, Netherlands)
|
July 12, 2024
Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer
Elaine Chang, Noah M Hahn, Seth P Lerner, et al.
The Journal of Urology
|
May 5, 2024
Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial
Vikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, et al.
The Lancet. Oncology
|
November 30, 2020
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, et al.
Page
of 74